The latest report by IMARC Group, titled “Adhesion Barriers Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“. The global adhesion barriers market size reached US$ 979.3 Million in 2022. Looking forward, IMARC Group expects the market to reach US$ 1,472.9 Million by 2028, exhibiting a growth rate (CAGR) of 7% during 2023-2028.
Adhesion barriers are gel, film, and liquid-based medical implants that act as a barrier to prevent post-surgical adhesions at the surgical site. They are manufactured using hyaluronic acid, polyethylene glycol, collagen, proteins, and fibrin. They are biocompatible, nonimmunogenic, anti-inflammatory, biodegradable, biomechanically strong, and have a degradation rate synchronized with tissue healing. They reduce abnormal internal scarring by separating the internal tissues and organs. At present, key market players are introducing various sprayable adhesion barriers that are easy to apply and conform to the irregularity of complex surfaces.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/adhesion-barriers-market/requestsample
Adhesion Barriers Market Trends and Drivers:
The growing geriatric population and increasing prevalence of pelvic and abdominal disorders, which include a high risk of postoperative complications due to numerous invasive procedures, represent one of the key factors catalyzing the demand for adhesion barriers across the globe. In line with this, the increasing adoption of adhesion barriers for use in gynecological, orthopedic, cardiovascular, urological, and reconstructive surgeries is propelling the market growth. Moreover, the flourishing healthcare sector and the growing provision of low-cost surgical procedures are creating a positive market outlook. Furthermore, increasing investments in research and development (R&D) activities to incorporate gene therapy for preventing post-surgical adhesion formation is projected to stimulate the growth of the market around the world.
Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Product:
- Synthetic
- Natural
Breakup by Formulation:
- FilmÂ
- LiquidÂ
- GelÂ
Breakup by Application:
- Gynecological Surgeries
- General/Abdominal Surgeries
- Cardiovascular Surgeries
- Orthopedic Surgeries
- Neurological Surgeries
- Reconstructive Surgeries
- Urological Surgeries
- Others
Breakup by Region:
- North America (U.S. & Canada)
- Europe (Germany, United Kingdom, France, Italy, Spain, Russia, and Others)
- Asia Pacific (China, India, Japan, South Korea, Indonesia, Australia, and Others)
- Latin America (Brazil, Mexico)
- Middle East & Africa
Competitors Landscape with Key Players:
- Anika Therapeutics, Inc.
- Atrium Medical Corporation
- Baxter International, Inc.
- Betatech Medical
- C. R. Bard Inc.
- FzioMed, Inc.,
- LifeSciences Corporation
- Medical Devices Business Services, Inc.
- MAST Biosurgery Inc.
- Groupe Sanofi
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact Us
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Email:Â sales@imarcgroup.com
Follow us on Twitter: @imarcglobal
